Therapeutic Cloning at a Standstill

Human Therapeutic Cloning at a Standstill Tuesday, 09 October 2007 It's rare for a scientist to take the mike at a prominent conference, face his peers, and plaintively announce that he has made absolutely no progress on an important research project. But that's exactly what Kevin Eggan, a biologist at the Harvard Stem Cell Institute, did last week at the Stem Cell Summit, in Boston. A year and a half after a highly publicized approval to start human therapeutic-cloning research at Harvard, Eggan and his collaborators have gotten nowhere. Despite extensive outreach, they still lack a crucial resource for their experiments: human eggs. "We've spent $100,000 on advertising, but we have yet to have a single woman donate eggs," says Eggan.

............................. Human Therapeutic Cloning at a Standstill A lack of human eggs has created a major roadblock in one of the most promising areas of stem-cell research. Technology Review - Tuesday, October 09, 2007 .........

ZenMaster

---

For more on stem cells and cloning, go to CellNEWS at http://www.geocities.com/giantfideli/index.html

---